In addition, the EBV-specific T cell repertoire in individuals with MS seems to be expanded [70], and EBV-specific CD8-positive T-cells are frequently observed in the CSF and in brain tissue at sites of white matter lesions and the meninges in MS [71,72]. Here, CD8A is linked to myeloid sarcoma.